HOME >> BIOLOGY >> NEWS
Leukemia drug turns mini-molecules up, cancer genes down

COLUMBUS , Ohio New research shows that a form of vitamin A used to treat acute promyelocytic leukemia induces changes in an unusual class of small molecules called microRNAs (miRNAs) in the leukemic cells.

The study also shows that three of these miRNAs inhibit the action of two genes important for cancer development, helping to explain how the drug works.

The drug is called all-trans-retinoic acid (ATRA) and it is considered the gold standard for treating the disease.

The study showed that ATRA raises the levels of three particular miRNAs in leukemia cells and that this rise coincides with a fall in activity of two important cancer-causing genes. The three are identified as miRNA-15b, miRNA-16-1 and let-7.

Two of these, miRNA-15b and miRNA-16-1, reduce the activity of the Bcl-2 gene, which is over-active in many kinds of cancer. The protein produced by this gene blocks the normal process of cell death and helps keep cancer cells alive long after they should have died.

The remaining miRNA molecule, let-7, lowered the activity of the Ras oncogene, an important cancer-causing gene. (Oncogenes are normal genes that when mutated lead to cancer.)

Researchers at the Ohio State University Comprehensive Cancer Center led the study, which was published in a recent issue of the journal Oncogene.

"The findings are important because they tell us that some miRNAs switch off genes that promote cancer," says first author Ramiro Garzon, a hematologist and oncologist at Ohio State's James Cancer Hospital and Solove Research Institute.

Acute promyelocytic leukemia occurs when cells that give rise to a form of white blood cell become stuck at an immature stage. The immature cells accumulate until they crowd out healthy white cells in the blood and bone marrow.

"Our findings suggest that these three miRNAs help re-program the malignant cells to a more normal state," Garzon says, "and that they a
'"/>

Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University
1-Mar-2007


Page: 1 2

Related biology news :

1. Loosen up, DNA: Leukemia gene changes genetic packaging
2. New treatment option breaks Leukemias resistance to chemotherapy, radiation therapy
3. VCU Massey Cancer Center researchers find new agent inhibits Leukemia cell survival
4. Leukemia, infection tied to aging stem cells, Stanford researchers say
5. OHSU turns mouse into factory for human liver cells
6. Jefferson researchers uncover new way nature turns genes on and off
7. Vax and Pax: Taking turns to build an eye
8. UC Riverside researchers show how the brain turns on innate behavior
9. NIH turns to FSU for top research on learning disabilities
10. Research shows how visual stimulation turns up genes to shape the brain
11. Hopkins researchers discover genetic switch that turns off an oxygen-poor cells combustion engine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/10/2019)... ... January 10, 2019 , ... When Dr. James L. ... , was invited to contribute a chapter to the new book Perinatal Stem Cells: ... continue Asymmetrex’s effort to address a debilitating secret of stem cell medicine. For ...
(Date:1/8/2019)... ... January 07, 2019 , ... Sonion ... for hearing instruments and specialty earphones, and Valencell , the leading innovator ... receiver in canal with an embedded biometric sensor. The BiometRIC measures key vital ...
(Date:1/4/2019)... WORTH, Texas (PRWEB) , ... January 02, 2019 ... ... catalog. This release is particularly noteworthy, as the life science tools and service ... history, it is offering a catalog. The catalog features not just part numbers ...
Breaking Biology News(10 mins):
(Date:1/20/2019)... Milwaukee (PRWEB) , ... January 17, 2019 , ... The ... release of its Patient Education program , a new initiative for 2019. Designed ... is designed to educate and inform patients, families, and the public on the status ...
(Date:1/15/2019)... BROOK, Ill. (PRWEB) , ... January 15, 2019 , ... ... risk factors for worsening kidney disease, according to a new study published in the ... stage and are frequently treated with partial nephrectomy, a surgical procedure in which the ...
(Date:1/11/2019)... ... January 11, 2019 , ... Drawing on over 22 years of software ... at 2:30pm EST will explore some of the key lessons that have driven customer ... vs. using multiple vendors, and find out how to ensure that you continue to ...
(Date:1/10/2019)... ... January 08, 2019 , ... VGI Medical was founded ... a leader in bringing innovation to the market including VerteLoc, CerLoc, SiJoin and VerteLP. ... joint by utilizing a unique patented dual geometric design to limit motion of the ...
Breaking Biology Technology:
Cached News: